Skip to main content
. Author manuscript; available in PMC: 2018 Jul 10.
Published in final edited form as: Clin Lung Cancer. 2017 Feb 9;18(5):559–564. doi: 10.1016/j.cllc.2017.01.012

Table 2.

Patients With Mixed Response to Pembrolizumab

Patient Site of Progression Intervention Total Duration of Response
VA001 RLL mass after cycle 3 XRT, 30 Gy >9.6 mo, continues to receive pembrolizumab with SD shown on imaging
VA003 RUL with SVC syndrome after cycle 5 XRT, 30 Gy 10.3 mo
VA009 New mediastinal lymph nodes after cycle 4 XRT, 20 Gy 6.5 mo
VA015 New brain mets after cycle 6 WBRT, 30 Gy 7.7 mo

Abbreviations: mets = metastases; RLL = right lower lobe; RUL = right upper lobe; SVC = superior vena cava; WBRT = whole brain radiation therapy; XRT = radiation therapy.